Diana Xochiquetzal Robledo-Cadena

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Top Venues

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Rodríguez-Enríquez, Diana Xochiquetzal Robledo-Cadena, Silvia Cecilia Pacheco-Velázquez, Jorge Luis Vargas-Navarro, Joaquín Alberto Padilla-Flores, Tuuli Kaambre, Rafael Moreno-Sánchez
Repurposing auranofin and meclofenamic acid as energy-metabolism inhibitors and anti-cancer drugs. PloS one 19 (9) (2024)
Juan Carlos Gallardo-Pérez, María Cristina Trejo-Solís, Diana Xochiquetzal Robledo-Cadena, Rebeca López-Marure, Lourdes Teresa Agredano-Moreno, Luis Felipe Jiménez-Garcia, Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma. Medical oncology (Northwood, London, England) 40 (3) (2023)
Juan Carlos Gallardo-Pérez, María Cristina Trejo-Solís, Diana Xochiquetzal Robledo-Cadena, Rebeca López-Marure, Lourdes Teresa Agredano-Moreno, Luis Felipe Jiménez-Garcia, Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma. Medical oncology (Northwood, London, England) 40 (3) (2023)
Juan Carlos Gallardo-Pérez, María Cristina Trejo-Solís, Diana Xochiquetzal Robledo-Cadena, Rebeca López-Marure, Lourdes Teresa Agredano-Moreno, Luis Felipe Jiménez-Garcia, Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma. Medical oncology (Northwood, London, England) 40 (3) (2023)